Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion

Bronte, 2000, Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells, Blood, 96, 3838, 10.1182/blood.V96.12.3838 Hoechst, 2011, Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells, Blood, 117, 6532, 10.1182/blood-2010-11-317321 Allavena, 2012, Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment, Clin Exp Immunol, 167, 195, 10.1111/j.1365-2249.2011.04515.x Almand, 2001, Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer, J Immunol, 166, 678, 10.4049/jimmunol.166.1.678 Hoechst, 2008, A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells, Gastroenterology, 135, 234, 10.1053/j.gastro.2008.03.020 Zea, 2005, Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion, Cancer Res, 65, 3044, 10.1158/0008-5472.CAN-04-4505 Dolcetti, 2010, Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF, Eur J Immunol, 40, 22, 10.1002/eji.200939903 Kwan, 2007, LPS induces rapid IL-10 release by M-CSF-conditioned tolerogenic dendritic cell precursors, J Leukoc Biol, 82, 133, 10.1189/jlb.0406267 Chou, 2011, Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice, Hepatology, 53, 1007, 10.1002/hep.24162 Ilkovitch, 2009, The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression, Cancer Res, 69, 5514, 10.1158/0008-5472.CAN-08-4625 Dangi, 2012, Selective expansion of allogeneic regulatory T cells by hepatic stellate cells: role of endotoxin and implications for allograft tolerance, J Immunol, 188, 3667, 10.4049/jimmunol.1102460 Schildberg, 2011, Murine hepatic stellate cells veto CD8 T cell activation by a CD54-dependent mechanism, Hepatology, 54, 262, 10.1002/hep.24352 Marigo, 2010, Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor, Immunity, 32, 790, 10.1016/j.immuni.2010.05.010 Mandruzzato, 2009, IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients, J Immunol, 182, 6562, 10.4049/jimmunol.0803831 Corzo, 2010, HIF-1{alpha} regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment, J Exp Med., 207, 2439, 10.1084/jem.20100587 Zhao, 2012, S100A9 a new marker for monocytic human myeloid derived suppressor cells, Immunology, 10.1111/j.1365-2567.2012.03566.x Movahedi, 2008, Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity, Blood, 111, 4233, 10.1182/blood-2007-07-099226 Marigo, 2008, Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells, Immunol Rev, 222, 162, 10.1111/j.1600-065X.2008.00602.x Kikuchi, 2005, Role of CD44 in epithelial wound repair: migration of rat hepatic stellate cells utilizes hyaluronic acid and CD44v6, J Biol Chem, 280, 15398, 10.1074/jbc.M414048200 Kimura, 2008, Critical role of CD44 in hepatotoxin-mediated liver injury, J Hepatol, 48, 952, 10.1016/j.jhep.2008.01.033 Urashima, 2000, Immunohistochemical study of hyaluronate receptor (CD44) in alcoholic liver disease, Alcohol Clin Exp Res, 24, 34S, 10.1111/j.1530-0277.2000.tb00009.x Endo, 2000, Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival, J Hepatol, 32, 78, 10.1016/S0168-8278(00)80192-0 Parker, 1995, Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins, Lancet, 345, 583, 10.1016/S0140-6736(95)90491-3 Thomson, 2010, Antigen-presenting cell function in the tolerogenic liver environment, Nat Rev Immunol, 10, 753, 10.1038/nri2858 Protzer, 2012, Living in the liver: hepatic infections, Nat Rev Immunol, 12, 201, 10.1038/nri3169 Ichikawa, 2011, Hepatic stellate cells function as regulatory bystanders, J Immunol, 186, 5549, 10.4049/jimmunol.1003917 Yu, 2004, Inhibition of T-cell responses by hepatic stellate cells via B7–H1-mediated T-cell apoptosis in mice, Hepatology, 40, 1312, 10.1002/hep.20488 Bronte, 2009, Myeloid-derived suppressor cells in inflammation: uncovering cell subsets with enhanced immunosuppressive functions, Eur J Immunol, 39, 2670, 10.1002/eji.200939892 Highfill, 2010, Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13, Blood, 116, 5738, 10.1182/blood-2010-06-287839 Tacke, 2012, Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species, Hepatology, 55, 343, 10.1002/hep.24700 Novo, 2009, Hepatic myofibroblasts: a heterogeneous population of multifunctional cells in liver fibrogenesis, Int J Biochem Cell Biol, 41, 2089, 10.1016/j.biocel.2009.03.010 Pylayeva-Gupta, 2012, Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia, Cancer Cell, 21, 836, 10.1016/j.ccr.2012.04.024 Hsieh, 2013, The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells, Blood, 121, 1760, 10.1182/blood-2012-06-440214 Safadi, 2002, Hepatic fibrosis-role of hepatic stellate cell activation, MedGenMed, 4, 27 Friedman, 2008, Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver, Physiol Rev, 88, 125, 10.1152/physrev.00013.2007 Lapidot, 2005, How do stem cells find their way home?, Blood, 106, 1901, 10.1182/blood-2005-04-1417 Ohata, 2009, Hematopoiesis-dependent expression of CD44 in murine hepatic progenitor cells, Biochem Biophys Res Commun, 379, 817, 10.1016/j.bbrc.2008.12.149 Ng, 2008, Two-photon imaging of effector T-cell behavior: lessons from a tumor model, Immunol Rev, 221, 147, 10.1111/j.1600-065X.2008.00596.x Hertweck, 2011, CD44 in hematological neoplasias, Ann Hematol, 90, 493, 10.1007/s00277-011-1161-z Nojima, 1992, Ligation of VLA-4 on T cells stimulates tyrosine phosphorylation of a 105-kD protein, J Exp Med, 175, 1045, 10.1084/jem.175.4.1045 Brown, 2011, CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression, J Clin Invest, 121, 1064, 10.1172/JCI44540 Braet, 2009, Three-dimensional organization of fenestrae labyrinths in liver sinusoidal endothelial cells, Liver Int, 29, 603, 10.1111/j.1478-3231.2008.01836.x Wiegard, 2005, Murine liver antigen presenting cells control suppressor activity of CD4+CD25+ regulatory T cells, Hepatology, 42, 193, 10.1002/hep.20756 Greten, 2011, Myeloid derived suppressor cells in human diseases, Int Immunopharmacol, 11, 802, 10.1016/j.intimp.2011.01.003 Chuaysri, 2009, Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma, Oncol Rep, 21, 957 Nakagawa, 2012, Inflammation- and stress-related signaling pathways in hepatocarcinogenesis, World J Gastroenterol, 18, 4071, 10.3748/wjg.v18.i31.4071